Netherlands Healthcare Providers & Services

Mainz Biomed NV (MYNZ)

Mainz Biomed NV experienced two notable transactions d'initiés recently, involving proposed sales by officer Guido Baechler totaling approximately 1.6 million dollars. These divestments occurred following the company's latest résultats financiers. Such activity reflects shifts in executive holdings, distinct from prior acquisition patterns observed within the firm's equity structure during the preceding fiscal period.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: MYNZ Exchange: NAS

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Mainz Biomed NV

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

BAECHLER GUIDO Officer Officer

Transaction date 22 May 2026

Proposed sale

Price

88.46

Quantity 25,408

Value US$2,428,779

BAECHLER GUIDO Policy-Making Officer Officer

Transaction date 15 May 2026

Proposed sale

Price

214.05

Quantity 16,388

Value US$3,923,324

Donahue Kevin Michael Large shareholder

Transaction date 17 Oct 2025

Purchase

Price

60.62

Quantity 92,634 -27.8%

Value US$799,140

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-05-22	2026-05-22	PrS Proposed sale	BAECHLER GUIDO Officer Officer	25,408 88.46 US$2,428,779	25,408	88.46	US$2,428,779
2026-05-18	2026-05-15	PrS Proposed sale	BAECHLER GUIDO Policy-Making Officer Officer	16,388 214.05 US$3,923,324	16,388	214.05	US$3,923,324
2026-01-16	2025-10-17	B Purchase	Donahue Kevin Michael Large shareholder	92,634 -27.8% 60.62 US$799,140	92,634 -27.8%	60.62	US$799,140